
60 Degrees Pharmaceuticals, Inc.
SXTPNASDAQHealthcare● Active
$1.43
+$0.01(+0.70%)
Market Cap$1153367
P/E Ratio—
52W High$12.96
52W Low$1.29
60 Degrees Pharmaceuticals, Inc.(SXTP)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · SXTP · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.01M | $0.61M | $0.25M | $0.22M | $1.16M |
| Cost of Revenue | $0.78M | $0.38M | $0.47M | $0.43M | $0.85M |
| Gross Profit | $0.22M | $0.22M | ($0.22M) | ($0.21M) | $0.31M |
| Gross Margin %(computed) | 22.26% | 36.67% | -87.15% | -93.71% | 26.68% |
| Operating Expenses | |||||
| R&D Expenses | $2.11M | $4.99M | $0.69M | $0.53M | $5.51M |
| G&A Expenses | $6.28M | $5.02M | $4.24M | $1.30M | $1.12M |
| Total Operating Expenses | $7.98M | $9.94M | $4.93M | $1.54M | $1.43M |
| Operating Income | ($7.76M) | ($9.71M) | ($5.15M) | ($1.75M) | ($1.12M) |
| Operating Margin %(computed) | -771.64% | — | — | -784.22% | -96.88% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.01M | $0.01M | $2.29M | $3.99M | $3.17M |
| Income Before Tax | ($7.37M) | ($7.96M) | ($3.81M) | ($6.18M) | ($4.26M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($7.37M) | ($7.95M) | ($3.77M) | ($6.18M) | ($4.25M) |
| Net Margin %(computed) | -732.82% | — | — | — | -366.42% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-11.73 | $-74.20 | $-3.80 | $-4.28 | $-2.96 |
| Wtd Avg Shares | 0.67M | 0.11M | 0.99M | 1.45M | 1.45M |
| EBITDA | ($7.28M) | ($7.88M) | ($1.43M) | ($2.11M) | ($1.01M) |
| EBITDA Margin %(computed) | -723.80% | — | -562.58% | -944.92% | -87.46% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M
深入了解60 Degrees Pharmaceuticals, Inc.
关于60 Degrees Pharmaceuticals, Inc.(SXTP)损益表
60 Degrees Pharmaceuticals, Inc.(SXTP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,SXTP实现营收$0.00B,毛利润$0.00B(毛利率22.26%),净利润($0.01B)(净利率-732.82%)。
常见问题
SXTP · 4 问60 Degrees Pharmaceuticals, Inc.(SXTP)2025财年营收为$0.00B,同比up65.5%。
SXTP revenueSXTP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08